期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
In vitro Study of Interstitial Combination Chemotherapy in the Treatment of Glioma 被引量:3
1
作者 杨正明 王明盛 陈坚 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第6期378-380,共3页
Objective: To investigate the inhibitory effects of combination chemotherapy of Carboplatin (CBP), Teniposide (Vm-26), Methasquin (MTX), and Nimodipine (NIM) on glioma, and to explore the sensitivity of gliom... Objective: To investigate the inhibitory effects of combination chemotherapy of Carboplatin (CBP), Teniposide (Vm-26), Methasquin (MTX), and Nimodipine (NIM) on glioma, and to explore the sensitivity of glioma cells to different treatment regimens so as to provide some clues for clinical usage of interstitial combination chemotherapy. Methods: MTT assay and 3H-TdR incorporation assay were performed to evaluate the inhibitory effects upon the proliferation of glioma cells, and to compare the sen- sitivity of glioma cells to administration of CBP, Vm-26, MTX, and NIM with that of the administration of CBP+NIM, Vm-26+NIM, MTX+NIM, CBP+Vm-26+MTX, or CBP+Vm-26+MTX+NIM, respectively. Results: The inhibition rate of CBP+Vm-26+MTX+NIM combination administration against glioma cells was 96.64%, higher than that of CBP+NIM (69.03%), Vm-26+NIM (71.53%), MTX+NIM (52.75%), CBP+Vm-26+MTX (78.59%) (P〈0.01), and the dosage of CBP, Vm-26, and MTX was declined to 1/10- 1/100 that of respective use of CBP, Vm-26, and MTX. Conclusion: The curative effect of combination administration of CBP, Vm-26, MTX, and NIM was much better than that of respective administration, suggesting a higher inhibition rate and a lower dosage use. 展开更多
关键词 GLIOMA combination administration interstitial chemotherapy
下载PDF
Sensitivity of Interstitial combined Chemotherapy against Glioma
2
作者 WANG Ming-sheng LIN Jian-ying ZHOU Guo-sheng ZHANG Xin-zhong 《医学信息(手术学分册)》 2006年第4期6-8,共3页
关键词 GLIOMA combination administration interstitial chemotherapy
下载PDF
Experimental Study on Therapeutic Effect of Combined Administration of Radix Salviae Miltiorrhizae. Ligustrazine and Radix Sanchi on Late Hemorrhagic Shock of Rabbits
3
作者 王志维 高尚志 +3 位作者 程邦昌 林道明 姚震 涂仲凡 《Chinese Journal of Integrative Medicine》 SCIE CAS 1998年第4期282-285,共4页
Objective: To explore the therapeutic mechanism of the combined use of Radix Salviae Miltiorrhizae, ligustrazine and Radix Sanchi in treating late hemorrhagic shock in rabbit. Methods: Rabbit hemorrhagic shock models ... Objective: To explore the therapeutic mechanism of the combined use of Radix Salviae Miltiorrhizae, ligustrazine and Radix Sanchi in treating late hemorrhagic shock in rabbit. Methods: Rabbit hemorrhagic shock models were set up according to Wiggers' method and treated with the combined therapy. Levels of RBC superoxide dismutase (SOD) activity, plasma malondialdehyde (MDA), blood lactate (BL) and magnesium (Mg++ ) were continuously monitored before shock, 120 minutes after shock, 60 and 120 minutes after reinfusion. Results: (1) Levels of SOD decreased and MDA, AL, Mg++ increased markedly 120 minutes after shock, indicating that there existed cell membrane damage caused by oxygen free radicals in hemorrhagic shock.(2) The combination therapy could alleviate lipid peroxidation injury to tissue, enhance the activity of SOD and lower the concentration of MDA significantly, P < 0. 01 or 0. 05, as compared with the control group. Conclusion: The combined use of the three drugs could gain the same effect with half dosage as that gained from the whole dosage of one single drug. It could also reduce the negative effect of treatment, such as hypotension and slowing down of heart rate 展开更多
关键词 Hemorrhagic shock Radix Salviae Miltiorrhizae LIGUSTRAZINE Radix Sanchi combined administration
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部